Genmab A (GMAB) Other Non Operating Income (2024 - 2026)
Genmab A (GMAB) reported Other Non Operating Income of -$163.0 million for Q1 2026, down 1353.85% on a YoY basis from $13.0 million in Q1 2025, and down 2816.67% quarter-over-quarter from $6.0 million in Q3 2025.
Genmab A (GMAB) Other Non Operating Income (2024 - 2026) Analysis & Trends
Genmab A has reported Other Non Operating Income for 3 years, with the latest figure at -$163.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Genmab A | 48.34 Bn | 46.82 Bn | 831.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -163.00 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Sep 30, 2024 | 129.00 Mn |
| Jun 30, 2024 | -30.00 Mn |
| Mar 31, 2024 | 7.00 Mn |